HHT telangiectases contain biallelic mutations in ENG/ACVRL1
Publication
, Conference
Snellings, DA; Gallione, CJ; Clark, DS; Vozoris, NT; Faughnan, ME; Marchuk, DA
Published in: ANGIOGENESIS
November 1, 2019
Duke Scholars
Published In
ANGIOGENESIS
EISSN
1573-7209
ISSN
0969-6970
Publication Date
November 1, 2019
Volume
22
Issue
4
Start / End Page
592 / 592
Publisher
SPRINGER
Related Subject Headings
- Oncology & Carcinogenesis
- 3101 Biochemistry and cell biology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Snellings, D. A., Gallione, C. J., Clark, D. S., Vozoris, N. T., Faughnan, M. E., & Marchuk, D. A. (2019). HHT telangiectases contain biallelic mutations in ENG/ACVRL1. In ANGIOGENESIS (Vol. 22, pp. 592–592). SPRINGER.
Snellings, D. A., C. J. Gallione, D. S. Clark, N. T. Vozoris, M. E. Faughnan, and D. A. Marchuk. “HHT telangiectases contain biallelic mutations in ENG/ACVRL1.” In ANGIOGENESIS, 22:592–592. SPRINGER, 2019.
Snellings DA, Gallione CJ, Clark DS, Vozoris NT, Faughnan ME, Marchuk DA. HHT telangiectases contain biallelic mutations in ENG/ACVRL1. In: ANGIOGENESIS. SPRINGER; 2019. p. 592–592.
Snellings, D. A., et al. “HHT telangiectases contain biallelic mutations in ENG/ACVRL1.” ANGIOGENESIS, vol. 22, no. 4, SPRINGER, 2019, pp. 592–592.
Snellings DA, Gallione CJ, Clark DS, Vozoris NT, Faughnan ME, Marchuk DA. HHT telangiectases contain biallelic mutations in ENG/ACVRL1. ANGIOGENESIS. SPRINGER; 2019. p. 592–592.
Published In
ANGIOGENESIS
EISSN
1573-7209
ISSN
0969-6970
Publication Date
November 1, 2019
Volume
22
Issue
4
Start / End Page
592 / 592
Publisher
SPRINGER
Related Subject Headings
- Oncology & Carcinogenesis
- 3101 Biochemistry and cell biology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1103 Clinical Sciences